Achieve Life Sciences (ACHV) Other Accumulated Expenses (2013 - 2026)

Achieve Life Sciences (ACHV) has 14 years of Other Accumulated Expenses data on file, last reported at $2.3 million in Q1 2026.

• Quarterly Other Accumulated Expenses rose 78.83% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 78.83% YoY) and the FY2025 annual result came in at $598000.0, up 4.36% from the prior year.
• Other Accumulated Expenses advanced to $2.3 million in Q1 2026, from $598000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.3 million in Q1 2026 to a low of $351000.0 in Q4 2023.
• A 5-year average of $881058.8 and a median of $693000.0 in 2023 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 207.11% — and 2024, when it dropped 17.95%.
• Tracing ACHV's Other Accumulated Expenses over 5 years: stood at $403000.0 in 2022, then decreased by 12.9% to $351000.0 in 2023, then surged by 63.25% to $573000.0 in 2024, then climbed by 4.36% to $598000.0 in 2025, then soared by 289.97% to $2.3 million in 2026.
• The last three Other Accumulated Expenses figures came in at $2.3 million (Q1 2026), $598000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.